Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials

We analyzed pooled data from two comparable randomized placebo-controlled clinical trials of bupropion pharmacotherapy for smoking cessation for which data on DRD2 Taq1A genotype were available. A total of 722 smokers across the two trials were randomized to 10 weeks of sustained-release bupropion h...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: David, Sean P., Strong, David R., Munafò, Marcus R., Brown, Richard A., Lloyd-Richardson, Elizabeth E., Wileyto, Paul E., Evins, Eden A., Shields, Peter G., Lerman, Caryn, Niaura, Raymond
格式: Artigo
語言:Inglês
出版: 2007
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2128730/
https://ncbi.nlm.nih.gov/pubmed/18058343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14622200701705027
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍